Stockscreener 앱 받기
165.11
6.63%
10.27
시간 외 거래:
166.03
0.92
+0.56%
Neurocrine Biosciences Inc 주식(NBIX)의 최신 뉴스
Neurocrine Biosciences shares jump on fresh long-term CRENESSITY data catalyst - Quiver Quantitative
NBIX Stock Draws Bullish Targets After Soleno Deal - StocksToTrade
Neurocrine Biosciences Jumps 5.8% Amid Sector-Wide Rally - AlphaStreet
Neurocrine to present two-year Crenessity data at ENDO 2026 - Investing.com
Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026 - PR Newswire
Goldman Sachs Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $213 - Moomoo
Neurocrine Biosciences Inc (NASDAQ:NBIX): A Peter Lynch GARP Opportunity with Strong Growth and a PEG Ratio of 0.82 - ChartMill
Neurocrine Biosciences CSO Jude Onyia sells $1.76m in stock - Investing.com UK
Neurocrine Biosciences chief regulatory officer sells $354,321 in stock By Investing.com - Investing.com Canada
Neurocrine Biosciences CSO Jude Onyia sells $1.76m in stock By Investing.com - Investing.com Nigeria
Neurocrine Biosciences chief regulatory officer sells $354,321 in stock - Investing.com
[Form 4] NEUROCRINE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Neurocrine (NASDAQ: NBIX) CRO sells 2,261 shares after option exercise - Stock Titan
24,965-share Rule 144 sale notice for Neurocrine (NASDAQ: NBIX) - Stock Titan
Goldman Sachs resumes Neurocrine Bio stock coverage with buy rating - Investing.com
Form 144: 11,000-share sale notice tied to option exercise (NBIX) - Stock Titan
Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 21% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Neurocrine Biosciences CSO Jude Onyia sells $1.71m in shares By Investing.com - Investing.com Australia
Neurocrine Biosciences CSO Jude Onyia sells $1.71m in shares - Investing.com UK
Neurocrine (NBIX) director Kevin Gorman receives grant of 5,248 stock options - Stock Titan
Neurocrine (NASDAQ: NBIX) CSO exercises options, sells 11,000 pre-planned shares - Stock Titan
NBIX (NBIX) director Richard Pops granted 2,567 Restricted Stock Units - Stock Titan
Neurocrine (NBIX) director granted stock options and RSUs as equity compensation - Stock Titan
Neurocrine Biosciences (NBIX) director receives 2,567 restricted stock units - Stock Titan
Director at Neurocrine (NASDAQ: NBIX) receives 2,567 RSUs as award - Stock Titan
Neurocrine (NBIX) director Stephen Sherwin receives 2,567 RSU equity grant - Stock Titan
Director at Neurocrine Biosciences (NASDAQ: NBIX) granted 2,567 RSUs - Stock Titan
Neurocrine (NASDAQ: NBIX) awards director 2,567 RSUs vesting in 2027 - Stock Titan
Neurocrine (NASDAQ: NBIX) grants options and RSUs to director - Stock Titan
RBC Capital Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $183 - Moomoo
Neurocrine Biosciences Should See More Upside on Crenessity Growth, RBC Says - Moomoo
A Look At Neurocrine Biosciences (NBIX) Valuation After New INGREZZA Data And Analyst Coverage - Sahm
RBC Lifts Price Target on Neurocrine Biosciences to $183 From $180, Keeps Outperform Rating - Moomoo
Neurocrine Biosciences Inc (NASDAQ:NBIX) Shows Strong Fundamentals and Bull Flag Breakout Setup - ChartMill
NBIX Stock Price, Quote & Chart | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - ChartMill
Neurocrine Biosciences’ David Boyer sells $609k in NBIX stock By Investing.com - Investing.com India
Neurocrine Biosciences’ David Boyer sells $609k in NBIX stock - Investing.com
Neurocrine (NBIX) executive sells 3,888 shares in pre-set 10b5-1 trade - Stock Titan
Neurocrine Biosciences (NBIX) 2026 meeting backs directors, pay and equity plan - Stock Titan
[144] NEUROCRINE BIOSCIENCES INC SEC Filing - Stock Titan
Neurocrine to buy Soleno Therapeutics for $2.9 billion - MSN
New Real‑World INGREZZA Data in Mild TD Might Change The Case For Investing In Neurocrine Biosciences (NBIX) - simplywall.st
NBIX (NASDAQ: NBIX) broker files Form 144 to sell 3,888 shares - Stock Titan
Neurocrine Biosciences to Present at Upcoming Investor Conferences in June - Yahoo Finance
Neurocrine to stream June investor fireside chats from Chicago, Miami - Stock Titan
Bernstein Initiates Coverage of Neurocrine Biosciences (NBIX) with Outperform - Insider Monkey
0.83%
3.98%
자본화:
|
볼륨(24시간):